Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates. - Wikidata - wikimedia - TriplyDB

Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates.

Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates.

http://www.wikidata.org/entity/Q34634976

about

Neural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challenges Molecular diagnostics of neurodegenerative disorders The choreography of neuroinflammation in Huntington's disease Mouse models of polyglutamine diseases: review and data table. Part I AAV-dominant negative tumor necrosis factor (DN-TNF) gene transfer to the striatum does not rescue medium spiny neurons in the YAC128 mouse model of Huntington's disease Does neuroinflammation fan the flame in neurodegenerative diseases?Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease Molecular Imaging Markers to Track Huntington’s Disease Pathology Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment.Mutant huntingtin impairs immune cell migration in Huntington disease.Application of "omics" to prion biomarker discovery.Serum levels of a subset of cytokines show high interindividual variability and are not altered in rats transgenic for Huntington´s disease Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression Microglial Activation in the Pathogenesis of Huntington's Disease.Abnormal peripheral chemokine profile in Huntington's disease The role of microglia in human disease: therapeutic tool or target?Downregulation of genes involved in metabolism and oxidative stress in the peripheral leukocytes of Huntington's disease patients.Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.Complement and HIV-I infection/HIV-associated neurocognitive disorders.A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons The role of the immune system in triplet repeat expansion diseases Cardiac Dysfunction in the BACHD Mouse Model of Huntington's Disease.The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice.Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood.Genetic Deficiency of Complement Component 3 Does Not Alter Disease Progression in a Mouse Model of Huntington's Disease.Bone marrow transplantation confers modest benefits in mouse models of Huntington's disease.Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington's disease.Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease.Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis.Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells.Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.JAK/STAT Signalling in Huntington's Disease Immune Cells.Genomic and Proteomic Biomarker Discovery in Neurological Disease.β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease.Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders.HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation.Huntington's disease: progress toward effective disease-modifying treatments and a cure

P2860

Q26775932-B7018294-37D7-4B39-81E6-FBA118BC9204 Q26786821-D54A6A6F-223F-45D8-9141-50053C60EF0B Q26828403-F2E47452-C86E-4D71-8E10-EE7D1A333E9B Q26853025-A6CE6116-3009-4411-AB27-E1714520AD9F Q27334472-D57C1802-97BE-47A3-84EA-8631D1F25081 Q27498993-D93B3F68-6206-4D98-9E6E-CF5769660642 Q28072237-C77D2666-0107-424C-849F-901D2795D122 Q28477022-ABA11713-6006-46B9-AAB6-124C07AB8FAF Q29248766-2972018E-BBE9-49B1-97FB-8DF6C8AAB83A Q30315395-CC04B44F-A947-4E32-BC8D-964ABA6A635D Q30530945-E6A057A2-8CCA-48AE-858B-ED66B206270E Q33708360-7032C250-6470-4541-A78D-B23DBA70D625 Q33730187-87A28DCB-1809-4BFD-92C8-DD55AC0BCD3A Q33755845-C2283E8D-1943-4982-8366-5A42C20864DE Q33809556-062BAED5-4351-4AAD-B78F-E04FBB3F6CA1 Q33985904-09406508-2AC8-438F-86F0-B02D79214F6B Q34038205-99E71804-3ADF-4D98-BDF9-E94BE92EBF07 Q34431341-1F69655A-DDE0-42B8-A017-9770C8B02408 Q34470414-95CFCB63-635B-4246-A1C4-5D8B5B5B017E Q34610122-5320099F-8EB6-4EFA-BB06-BE79FF0E5EAD Q34795840-781D99EF-246C-4266-B7BD-7DBCB9FC5C1C Q35103285-6549A950-BFCB-4F41-9F59-848594E3B6D0 Q35271805-2F7F384D-A3E8-4513-BB1D-024CF9F5F79D Q35903061-2378E5C7-674E-45D8-9F38-2044958DB22D Q35975087-A869CA1C-FE31-4644-BA04-A955D1DDA9E5 Q36116666-010E2CDA-8DD8-440A-8BBA-2CD58D3B7975 Q36338269-6AF634C7-9166-4AB0-9E54-E3433901E5EA Q36608360-1CFC9883-62A4-4943-BD87-5EDF8188243D Q37040974-04ED7373-8B0A-43E5-A54C-0FCE188DBE74 Q37113861-135A04FD-F1FC-4AA3-AADB-C8E09CE937C1 Q37120339-95D3D76A-941D-42B3-8B52-8068F5952C01 Q37165188-8E227FD0-85B7-4EB3-8DFC-B1BBC80C35D4 Q37169655-F4E7042E-D83B-419E-8F94-07BE5057E848 Q37296047-B7BC5CA5-8CE1-48B1-B4BF-D1214256EFE9 Q37410973-98F26437-1205-4E6C-9957-30ABD36209DE Q37541706-F6FFBA7F-2ED5-4D56-A066-A5035F3E1552 Q37603963-A5609195-F597-4206-9E4C-1A5226B647AF Q37691267-08C30291-0411-4D74-98B9-ADAA43EFF59C Q37697482-6B3F2462-E59F-4981-A2DD-3BE1EF1E93E6 Q37737477-6FE92070-CFD6-4E88-BF4F-5A9C603480FF

P2860

Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates.

http://www.wikidata.org/entity/Q34634976

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Proteomic profiling of plasma ...... tion and biomarker candidates.

@ast

Proteomic profiling of plasma ...... tion and biomarker candidates.

@en

Proteomic profiling of plasma ...... tion and biomarker candidates.

@nl

type

label

Proteomic profiling of plasma ...... tion and biomarker candidates.

@ast

Proteomic profiling of plasma ...... tion and biomarker candidates.

@en

Proteomic profiling of plasma ...... tion and biomarker candidates.

@nl

prefLabel

Proteomic profiling of plasma ...... tion and biomarker candidates.

@ast

Proteomic profiling of plasma ...... tion and biomarker candidates.

@en

Proteomic profiling of plasma ...... tion and biomarker candidates.

@nl

P1433

Q34634976-DC5DB830-F0A8-4683-B084-600B3CC25C69

P1476

Q34634976-501BEE24-454B-4C6E-886E-C46A85F8E92C

P2093

Q34634976-0739E46A-4510-4CE6-B8B5-F90F271C8910

Q34634976-478AF739-7A55-4583-9B31-DE4D78533EEF

Q34634976-49030682-370A-4370-A8A1-C499380123F7

Q34634976-5A167962-12A2-4190-8D9D-771DF2661526

Q34634976-836B5842-2EBD-48B0-8680-8917D262CF8B

Q34634976-898D785F-F59C-4960-A937-AD892604EE32

Q34634976-B1304C33-990D-4102-856A-AD4C8625B68C

Q34634976-C4977CCC-32AD-4710-8F5C-656913D12E95

P304

Q34634976-3EE5098E-A20B-4D50-937F-267844FB5161

P31

Q34634976-52B3E9BF-3A44-43E4-8859-D330030E05D8

P356

Q34634976-81AE4C39-A57C-490E-8187-7E9717EA80F2

P433

Q34634976-8CA40739-E3FC-470F-819B-93D53FD82283

P478

Q34634976-D1254E11-9E4F-4E12-843E-70F5622CACAC

P50

Q34634976-29D741BD-7BDD-4CCC-9E70-011E2226041C

Q34634976-54BA4426-B544-44AC-9C1D-1C7B9733052E

Q34634976-5C94C3C5-9A63-4764-810F-509044E94C41

Q34634976-B25EBBE6-643B-4B13-B9D9-134A006CBA82

Q34634976-D5413F13-268C-453C-A3D9-33AA252E0EC0

Q34634976-E7053BBC-F0FF-498D-B2EA-1C882B0BCA01

P577

Q34634976-F01240A0-0F14-4C6D-8B72-F4C5343DBB9D

P5875

Q34634976-6E32A684-D007-474C-B7A8-D6493B4EF705

P698

Q34634976-5EF261B8-263A-47FD-BAE1-FDAE501986CB

P921

Q34634976-3043AA28-6479-4409-9380-77FE542A5E1E

Q34634976-654063B5-8B68-4CCD-B84B-93949AF5F9F5

P356

P1433

Journal of Proteome Research

P1476

Proteomic profiling of plasma ...... tion and biomarker candidates.

@en

P2093

Annette Dalrymple

http://www.w3.org/2001/XMLSchema#string

Asa Petersén

http://www.w3.org/2001/XMLSchema#string

Geoff Keir

http://www.w3.org/2001/XMLSchema#string

Jeremy D Isaacs

http://www.w3.org/2001/XMLSchema#string

Kirupa Sathasivam

http://www.w3.org/2001/XMLSchema#string

Maria Björkqvist

http://www.w3.org/2001/XMLSchema#string

Mark Kristiansen

http://www.w3.org/2001/XMLSchema#string

Richard Joubert

http://www.w3.org/2001/XMLSchema#string

P304

2833-2840

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/PR0700753

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Sarah J. Tabrizi

Graham S Jackson

Blair R Leavitt

P577

2007-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6283352

http://www.w3.org/2001/XMLSchema#string

P698

17552550

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease